SEC Form 3 · accession 0001209191-19-018628
TENET HEALTHCARE CORP · THC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Hacker
Officer — EVP, Chief Compliance Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 11, 2019 · 8:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070318
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 2,434 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 May Restricted Stock UnitsF2,F1 | — | holding | — | — | — | — | — | Common Stock | 4,032 | — | D |
| 2016 May Performance-Based Restricted Stock UnitsF2,F3 | — | holding | — | — | — | — | — | Common Stock | 2,188 | — | D |
| 2017 March Restricted Stock UnitsF2,F4 | — | holding | — | — | — | — | — | Common Stock | 1,756 | — | D |
| 2017 March Performance Stock Options (Right to Buy)F5 | $18.99 | holding | — | — | — | — | Mar 1, 2027 | Common Stock | 11,736 | — | D |
| 2018 February Restricted Stock UnitsF2,F6 | — | holding | — | — | — | — | — | Common Stock | 3,237 | — | D |
| 2018 February Performance Stock Options (Right to Buy)F7 | $20.60 | holding | — | — | — | — | Feb 28, 2028 | Common Stock | 11,326 | — | D |
| 2019 February Restricted Stock UnitsF2,F8 | — | holding | — | — | — | — | — | Common Stock | 3,539 | — | D |
| 2019 February Performance Stock Options (Right to Buy)F9 | $28.26 | holding | — | — | — | — | Feb 27, 2029 | Common Stock | 8,007 | — | D |
Explanation of responses
- F1These time-based restricted stock units vest in full on May 31, 2019.
- F2Restricted stock units are settled in shares of the Company's common stock upon vesting.
- F3On May 31, 2016, the reporting person received a target grant of 5,184 performance-based restricted stock units that were subject to the Company's achievement of specified performance goals for the three year period that ended on December 31, 2018. The actual number of stock units that could vest ranged from 0% to 200% of the target unit amount. The performance goals were achieved in part, and 42.2% of the target grant was awarded; therefore, 2,188 restricted stock units will vest and settle on May 31, 2019.
- F4These time-based restricted stock units vest in full on March 1, 2020.
- F5These performance-based stock options will vest on March 1, 2020, as the stock price performance condition has been satisfied.
- F6Half of these time-based restricted stock units vest on each of February 28, 2020 and 2021.
- F7These performance-based stock options will vest on February 28, 2021, as the stock price performance condition has been satisfied.
- F8One-third of these time-based restricted stock units vest on each of February 27, 2020, 2021 and 2022.
- F9These performance-based stock options vest on February 27, 2022, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $35.33 per share for any 20 consecutive trading days during the three-year period following the date of grant, which was February 27, 2019.